Pharmacological and non-pharmacological interventions to influence adipose tissue function

Por Westerink, Jan, Visseren, Frank LJ
Publicado em 2011

The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications

Por de Graaf, Gimon, Postmus, Douwe, Westerink, Jan, Buskens, Erik
Publicado no Cost Eff Resour Alloc (2018)

Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled cros...

Por Koopal, Charlotte, Marais, A. David, Westerink, Jan, van der Graaf, Yolanda, Visseren, Frank L. J.
Publicado no J Lipid Res (2017)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials

Por de Jong, Marit, van der Worp, H. Bart, van der Graaf, Yolanda, Visseren, Frank L. J., Westerink, Jan
Publicado no Cardiovasc Diabetol (2017)

Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs

Por Liu, Ying Poi, von Eije, Karin Jasmijn, Schopman, Nick CT, Westerink, Jan-Tinus, Brake, Olivier ter, Haasnoot, Joost, Berkhout, Ben
Publicado em 2009

Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies

Por Liu, Ying Poi, Vink, Monique A., Westerink, Jan-Tinus, Ramirez de Arellano, Eva, Konstantinova, Pavlina, Ter Brake, Olivier, Berkhout, Ben
Publicado em 2010

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular di...

Por Bots, Sophie H., van der Graaf, Yolanda, Nathoe, Hendrik M. W., de Borst, Gert Jan, Kappelle, Jaap L., Visseren, Frank L. J., Westerink, Jan
Publicado no Cardiovasc Diabetol (2016)